Three-dimensional bio-printing: A new frontier in oncology research

Current research in oncology deploys methods that rely principally on two-dimensional (2D) mono-cell cultures and animal models. Although these methodologies have led to significant advancement in the development of novel experimental therapeutic agents with promising anticancer activity in the laboratory, clinicians still struggle to manage cancer in the clinical setting. The disappointing translational success is attributable mainly to poor representation and recreation of the cancer microenvironment present in human neoplasia. Three-dimensional (3D) bio-printed models could help to simulate this micro-environment, with recent bio-printing of live human cells demonstrating that effective in vitro replication is achievable. This literature review outlines up-to-date advancements and developments in the use of 3D bio-printed models currently being used in oncology research. These innovative advancements in 3D bio-printing open up a new frontier for oncology research and could herald an era of progressive clinical cancer therapeutics.

[1]  R. Klebe,et al.  Cytoscribing: a method for micropositioning cells and the construction of two- and three-dimensional synthetic tissues. , 1988, Experimental cell research.

[2]  Pankaj Karande,et al.  Design and fabrication of human skin by three-dimensional bioprinting. , 2014, Tissue engineering. Part C, Methods.

[3]  Wim E Hennink,et al.  25th Anniversary Article: Engineering Hydrogels for Biofabrication , 2013, Advanced materials.

[4]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[5]  Bertrand Guillotin,et al.  Laser-assisted bioprinting to deal with tissue complexity in regenerative medicine , 2011 .

[6]  Paul Theodor Pyl,et al.  The Genomic and Transcriptomic Landscape of a HeLa Cell Line , 2013, G3: Genes, Genomes, Genetics.

[7]  J. Tobert,et al.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors , 2003, Nature Reviews Drug Discovery.

[8]  S. Orsulic,et al.  Mouse models of cancer. , 2011, Annual review of pathology.

[9]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[10]  Yu Sun.  Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures , 2015, Medicinal research reviews.

[11]  P. Sandercock,et al.  Comparison of treatment effects between animal experiments and clinical trials: systematic review , 2006, BMJ : British Medical Journal.

[12]  J. Toyn.  What lessons can be learned from failed Alzheimer’s disease trials? , 2015, Expert review of clinical pharmacology.

[13]  V. Seshan,et al.  A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.

[14]  J. Samitier,et al.  Bioprinting of 3D hydrogels. , 2015, Lab on a chip.

[15]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[16]  Alastair Droop,et al.  Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions , 2008, Genome Biology.

[17]  Xiaofeng Cui,et al.  Inkjet-bioprinted acrylated peptides and PEG hydrogel with human mesenchymal stem cells promote robust bone and cartilage formation with minimal printhead clogging. , 2015, Biotechnology journal.

[18]  JONG BIN Kim,et al.  Three-dimensional tissue culture models in cancer biology. , 2005, Seminars in cancer biology.

[19]  C. Belzung.  Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects? , 2014, Neuropsychopharmacology.

[20]  Jesper Gantelius,et al.  3D Bioprinting of Tissue/Organ Models. , 2016, Angewandte Chemie.

[21]  G. Opelz,et al.  Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation , 1995, The Lancet.

[22]  M Nakamura,et al.  Biomatrices and biomaterials for future developments of bioprinting and biofabrication , 2010, Biofabrication.

[23]  M. M. Stanton,et al.  Bioprinting of 3 D hydrogels , 2015 .

[24]  David Butler,et al.  Tissue engineering and developmental biology: going biomimetic. , 2006, Tissue engineering.

[25]  K. Flaherty,et al.  The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα. , 2014, Cancer discovery.

[26]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[27]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[28]  J. Dittmer,et al.  The impact of tumor stroma on drug response in breast cancer. , 2015, Seminars in cancer biology.

[29]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[30]  Fumiyoshi Yamashita,et al.  In silico approaches for predicting ADME properties of drugs. , 2004, Drug metabolism and pharmacokinetics.

[31]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[32]  Wei Sun,et al.  Precision extruding deposition (PED) fabrication of polycaprolactone (PCL) scaffolds for bone tissue engineering , 2009, Biofabrication.

[33]  Yongnian Yan,et al.  In Vitro Angiogenesis of 3D Tissue Engineered Adipose Tissue , 2009 .

[34]  C. Cannon.  Learning lessons from Pfizer's $800 million failure , 2011, Nature Reviews Drug Discovery.

[35]  Benjamin M Wu,et al.  Recent advances in 3D printing of biomaterials , 2015, Journal of Biological Engineering.

[36]  M. Boeckh,et al.  Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed? , 2011, Current Opinion in Virology.

[37]  K. Jin,et al.  Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[38]  L. Niklason,et al.  Scaffold-free vascular tissue engineering using bioprinting. , 2009, Biomaterials.

[39]  Brendon M. Baker,et al.  Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues , 2012 .

[40]  G. Giaccone,et al.  The multilayered postconfluent cell culture as a model for drug screening. , 2000, Critical reviews in oncology/hematology.

[41]  Brendon M. Baker,et al.  Rapid casting of patterned vascular networks for perfusable engineered 3D tissues , 2012, Nature materials.

[42]  Thierry F Vandamme,et al.  Rodent models for human diseases. , 2015, European journal of pharmacology.

[43]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[44]  Sean Murphy,et al.  Amnion epithelial cell isolation and characterization for clinical use. , 2010, Current protocols in stem cell biology.

[45]  J. Belizário.  Immunodeficient Mouse Models: An Overview , 2009 .

[46]  James J. Yoo,et al.  Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. , 2013, Biomaterials.

[47]  Liquid Biopsies.  Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.

[48]  Nan Ma,et al.  Laser printing of skin cells and human stem cells. , 2010, Tissue engineering. Part C, Methods.

[49]  Glenn D Prestwich,et al.  Bioprinting vessel-like constructs using hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. , 2010, Biomaterials.

[50]  W. Dhert,et al.  Three-dimensional fiber deposition of cell-laden, viable, patterned constructs for bone tissue printing. , 2008, Tissue engineering. Part A.

[51]  K. Cheung,et al.  Hydrogel-based microfluidic systems for co-culture of cells , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[52]  Mary C Phelan,et al.  Basic Techniques in Mammalian Cell Tissue Culture , 1998, Current protocols in cell biology.

[53]  Joseph M. Negri,et al.  The role of tumour–stromal interactions in modifying drug response: challenges and opportunities , 2013, Nature Reviews Drug Discovery.

[54]  V Mironov,et al.  Biofabrication: a 21st century manufacturing paradigm , 2009, Biofabrication.

[55]  M. Ghert,et al.  Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.

[56]  P. Jänne,et al.  The quest to overcome resistance to EGFR-targeted therapies in cancer , 2013, Nature Medicine.

[57]  F. Dammacco,et al.  Targeted therapies in cancer , 2018, Surgery (Oxford).

[58]  S. Corso,et al.  Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. , 2013, Cancer discovery.

[59]  M. Jordan,et al.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Ikonomidou,et al.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? , 2002, The Lancet Neurology.

[62]  Anthony Atala,et al.  3D bioprinting of tissues and organs , 2014, Nature Biotechnology.

[63]  M. Cekanova,et al.  Animal models and therapeutic molecular targets of cancer: utility and limitations , 2014, Drug design, development and therapy.

[64]  Emilio Benfenati,et al.  In silico methods to predict drug toxicity. , 2013, Current opinion in pharmacology.

[65]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[66]  J A Barron,et al.  Biological Laser Printing: A Novel Technique for Creating Heterogeneous 3-dimensional Cell Patterns , 2004, Biomedical microdevices.

[67]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[68]  F. Marga,et al.  Toward engineering functional organ modules by additive manufacturing , 2012, Biofabrication.

[69]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[70]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[71]  Mohini Gore,et al.  Computer-aided drug designing. , 2014, Methods in molecular biology.

[72]  D. Spandidos,et al.  Uterine cervical carcinoma: role of matrix metalloproteinases (review). , 2009, International journal of oncology.

[73]  S. Sahoo,et al.  3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.

[74]  F. Guillemot,et al.  High-throughput laser printing of cells and biomaterials for tissue engineering. , 2010, Acta biomaterialia.

[75]  S. Strom,et al.  Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. , 2010, Methods in molecular biology.

[76]  J. Lewis,et al.  3D Bioprinting of Vascularized, Heterogeneous Cell‐Laden Tissue Constructs , 2014, Advanced materials.

[77]  T. Boland,et al.  Inkjet printing of viable mammalian cells. , 2005, Biomaterials.

[78]  E. Rofstad,et al.  Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors , 2009, Journal of Cancer Research and Clinical Oncology.

[79]  Sheryl Knab.  The Price of Innovation , 2010 .

[80]  G. Hu,et al.  New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.

[81]  J. Rosen,et al.  Modelling breast cancer: one size does not fit all , 2007, Nature Reviews Cancer.

[82]  P. Vogt,et al.  Tissue Engineered Skin Substitutes Created by Laser-Assisted Bioprinting Form Skin-Like Structures in the Dorsal Skin Fold Chamber in Mice , 2013, PloS one.

[83]  M. Mann,et al.  Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions , 2009, Molecular & Cellular Proteomics.

[84]  M. Moridani,et al.  Drug development and discovery: challenges and opportunities. , 2014, Drug discovery today.

[85]  H. Coon,et al.  Culture of hormone-dependent functional epithelial cells from rat thyroids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M. Schymura,et al.  Cancer incidence in New York State acquired immunodeficiency syndrome patients. , 2001, American journal of epidemiology.

[87]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[88]  J. Kassis,et al.  3D in vitro tissue models and their potential for drug screening , 2013, Expert opinion on drug discovery.

[89]  A. Khademhosseini,et al.  Modular Tissue Engineering: Engineering Biological Tissues from the Bottom Up. , 2009, Soft matter.

[90]  K. Yoshizato,et al.  Chimeric mice with humanized liver. , 2008, Toxicology.

[91]  C. Lehr,et al.  A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. , 2010, Molecular pharmaceutics.

[92]  Vladimir Mironov,et al.  Bioprinting is coming of age: report from the International Conference on Bioprinting and Biofabrication in Bordeaux (3B'09) , 2010, Biofabrication.

[93]  W. Sommergruber,et al.  IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction , 2014, Oncogene.

[94]  Marc L. Mendillo,et al.  The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy , 2014, Cell.

[95]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[96]  Liliang Ouyang,et al.  Three-dimensional printing of Hela cells for cervical tumor model in vitro , 2014, Biofabrication.

[97]  D. Redelmeier,et al.  Translation of research evidence from animals to humans. , 2006, JAMA.

[98]  Yu Sun,et al.  Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies? , 2014, Protein & Cell.

[99]  Y. Harazono,et al.  Why anti-Bcl-2 clinical trials fail: a solution , 2013, Cancer and Metastasis Reviews.

[100]  K Schmidt-Nielsen,et al.  Scaling in biology: the consequences of size. , 1975, The Journal of experimental zoology.

[101]  D. Cho,et al.  Bioprinting of a mechanically enhanced three-dimensional dual cell-laden construct for osteochondral tissue engineering using a multi-head tissue/organ building system , 2012 .

[102]  D. Greiner,et al.  Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.

[103]  Yongnian Yan,et al.  In Vitro Angiogenesis of 3D Tissue Engineered Adipose Tissue , 2009 .

[104]  K. Morishima,et al.  Bio rapid prototyping by extruding/aspirating/refilling thermoreversible hydrogel , 2010, Biofabrication.

[105]  Xiaofeng Cui,et al.  Thermal inkjet printing in tissue engineering and regenerative medicine. , 2012, Recent patents on drug delivery & formulation.

[106]  M. Teitell,et al.  Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. , 2007, Cancer cell.

[107]  Vladimir Mironov,et al.  Organ printing: computer-aided jet-based 3D tissue engineering. , 2003, Trends in biotechnology.

[108]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[109]  A. G. de Herreros,et al.  Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer , 2013, Clinical Cancer Research.

[110]  N. Kulagina,et al.  Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. , 1974, Experimental hematology.

[111]  Kwok-Kin Wong,et al.  New cast for a new era: preclinical cancer drug development revisited. , 2013, The Journal of clinical investigation.

[112]  Luke A. Gilbert,et al.  DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.

[113]  John W Haycock,et al.  3D cell culture: a review of current approaches and techniques. , 2011, Methods in molecular biology.

[114]  Peter J Houghton,et al.  Establishment of human tumor xenografts in immunodeficient mice , 2007, Nature Protocols.

[115]  H. Dvorak,et al.  Tumor microenvironment and progression , 2011, Journal of surgical oncology.

[116]  Tao Xu,et al.  Inkjet-mediated gene transfection into living cells combined with targeted delivery. , 2009, Tissue engineering. Part A.

[117]  Hod Lipson,et al.  Direct Freeform Fabrication of Seeded Hydrogels in Arbitrary Geometries , 2022 .